Cargando…

Association of Non-LDL Indices with Recurrent Stroke Risk while on Lipid-Modifying Therapy

Aims: Low-density lipoprotein (LDL)-lowering statin therapy is an established secondary stroke prevention strategy. However, the differential impact of key non-LDL levels on recurrent stroke risk, while on lipid-modifying therapy (LT), remains unclear. Methods: We analyzed the dataset of a multicent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Jong-Ho, Ovbiagele, Bruce
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Atherosclerosis Society 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049477/ https://www.ncbi.nlm.nih.gov/pubmed/31189759 http://dx.doi.org/10.5551/jat.49304

Ejemplares similares

Risk of recurrent stroke and antiplatelet choice in breakthrough stroke while on aspirin
por: Kim, Joon-Tae, et al.
Publicado: (2020)

LDL-C levels, lipid-lowering treatment and recurrent stroke in minor ischaemic stroke or TIA
por: Pan, Yuesong, et al.
Publicado: (2022)

Factors associated with incidence of stroke and heart failure among people living with HIV in Ghana: Evaluating Vascular Event Risk while on Long‐Term Antiretroviral Suppressive Therapy (EVERLAST) Study
por: Sarfo, Fred Stephen, et al.
Publicado: (2021)

Association of Optimal Combination Drug Treatment with Obesity Status among Recent Ischemic Stroke Patients: Results of the Vitamin Intervention for Stroke Prevention (VISP) Trial
por: Park, Jong-Ho, et al.
Publicado: (2017)

New and emerging lipid-modifying drugs to lower LDL cholesterol
por: Kosmas, Constantine E, et al.
Publicado: (2021)

Update on Antithrombotic Therapy for Stroke Prevention in Atrial Fibrillation
por: Abcede, Hermelinda G., et al.
Publicado: (2010)

Trends in Incident and Recurrent Rates of First-Ever Ischemic Stroke in Taiwan between 2000 and 2011
por: Lee, Meng, et al.
Publicado: (2016)

Evaluation of Vascular Event Risk while on Long-term Anti-retroviral Suppressive Therapy [EVERLAST]: Protocol for a prospective observational study
por: Sarfo, Fred Stephen, et al.
Publicado: (2019)

Cumulative Effects of LDL Cholesterol and CRP Levels on Recurrent Stroke and TIA
por: Kitagawa, Kazuo, et al.
Publicado: (2019)

The Contribution of Inflammation to Stroke Recurrence Attenuates at Low LDL-C Levels
por: Zhang, Xing, et al.
Publicado: (2022)

Lipid-lowering therapies and achievement of LDL-cholesterol targets
por: Rizzo, Manfredi, et al.
Publicado: (2012)

Unrecognized History of Transient Atrial Fibrillation at the Time of Discharge from an Index Stroke Hospitalization Is Associated with Increased Recurrent Stroke Risk
por: Hsu, Chia-Yu, et al.
Publicado: (2019)

Prevalence and influence of chronic obstructive pulmonary disease on stroke outcomes in hospitalized stroke patients
por: Lekoubou, Alain, et al.
Publicado: (2016)

Utilization of Statins Beyond the Initial Period After Stroke and 1‐Year Risk of Recurrent Stroke
por: Lee, Meng, et al.
Publicado: (2017)

Dominant modifiable risk factors for stroke in Ghana and Nigeria (SIREN): a case-control study
por: Owolabi, Mayowa O, et al.
Publicado: (2018)

ApoB and Non‐HDL Cholesterol Versus LDL Cholesterol for Ischemic Stroke Risk
por: Johannesen, Camilla D. L., et al.
Publicado: (2022)

Electronegative LDL: A Circulating Modified LDL with a Role in Inflammation
por: Estruch, Montserrat, et al.
Publicado: (2013)

Is clopidogrel better than aspirin following breakthrough strokes while on aspirin? A retrospective cohort study
por: Lee, Meng, et al.
Publicado: (2014)

Discordance of Non-HDL and Directly Measured LDL Cholesterol: Which Lipid Measure is Preferred When Calculated LDL Is Inaccurate?
por: Baruch, Lawrence, et al.
Publicado: (2013)

Recurrent Lupus Enteritis While on Chronic Immunosuppressant Therapy
por: Bindukumari Sureshkumar, Nandhini, et al.
Publicado: (2022)

Intravenous Thrombolysis in Ischemic Stroke Patients with Intracranial Neoplasms: Two Cases and a Literature Review
por: Neil, William, et al.
Publicado: (2011)

Predicting Chronic Subdural Hematoma Recurrence and Stroke Outcomes While Withholding Antiplatelet and Anticoagulant Agents
por: Zanaty, Mario, et al.
Publicado: (2020)

Activation of GPR55 Receptors Exacerbates oxLDL-Induced Lipid Accumulation and Inflammatory Responses, while Reducing Cholesterol Efflux from Human Macrophages
por: Lanuti, Mirko, et al.
Publicado: (2015)

Effect of pre-diabetes on future risk of stroke: meta-analysis
por: Lee, Meng, et al.
Publicado: (2012)

LDL-Migration Index (LDL-MI), an Indicator of Small Dense Low-Density Lipoprotein (sdLDL), Is Higher in Non-Alcoholic Steatohepatitis than in Non-Alcoholic Fatty Liver: A Multicenter Cross-Sectional Study
por: Imajo, Kento, et al.
Publicado: (2014)

Large Left Ventricular Thrombus as a Cause of Recurrent Cardioembolic Stroke While on Dabigatran
por: Moey, Melissa Y.Y., et al.
Publicado: (2018)

Correction: Activation of GPR55 Receptors Exacerbates oxLDL-Induced Lipid Accumulation and Inflammatory Responses, while Reducing Cholesterol Efflux from Human Macrophages
por: Lanuti, Mirko, et al.
Publicado: (2015)

LDL retention time in plasma can be -based on causation- estimated by the lipid composition of LDL and other lipoproteins
por: Jansen, Martin, et al.
Publicado: (2022)

Use of non‐LDL‐C lipid‐lowering medications in patients with type 2 diabetes
por: Arnold, Suzanne V., et al.
Publicado: (2020)

Low glomerular filtration rate and risk of stroke: meta-analysis
por: Lee, Meng, et al.
Publicado: (2010)

Achievement of LDL-C Targets Defined by ESC/EAS (2011) Guidelines in Risk-Stratified Korean Patients with Dyslipidemia Receiving Lipid-Modifying Treatments
por: Yang, Ye Seul, et al.
Publicado: (2020)

Elevated Pulse Pressure and Recurrent Hemorrhagic Stroke Risk in Stroke With Cerebral Microbleeds or Intracerebral Hemorrhage
por: Park, Jong‐Ho, et al.
Publicado: (2022)

Clearance and Utilization of Dicarbonyl-Modified LDL in Monkeys and Humans
por: Lankin, Vadim Z., et al.
Publicado: (2023)

Prior intracerebral hemorrhage and white matter hyperintensity burden on recurrent stroke risk
por: Park, Jong-Ho, et al.
Publicado: (2021)

Decompressive hemicraniectomy for stroke by race/ethnicity in the United States
por: Lekoubou, Alain, et al.
Publicado: (2022)

Implications of the obesity epidemic for lipid-lowering therapy: Non-HDL cholesterol should replace LDL cholesterol as the primary therapeutic target
por: Hoenig, Michel R
Publicado: (2008)

Effects of endovascular therapy for mild stroke due to proximal or M2 occlusions: meta-analysis
por: Lin, Chun-Hsien, et al.
Publicado: (2023)

Effects of copper sulfate-oxidized or myeloperoxidase-modified LDL on lipid loading and programmed cell death in macrophages under hypoxia
por: Vlaminck, Benoit, et al.
Publicado: (2014)

High-phosphorus diets reduce aortic lesions and cardiomyocyte size and modify lipid metabolism in Ldl receptor knockout mice
por: Grundmann, Sarah M., et al.
Publicado: (2020)

Estimation of the LDL subclasses in ischemic stroke as a risk factor in a Chinese population
por: Duan, Ruisheng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hjnsjp4u8rbq9h8b6l4d104iuf